Ka-On Lam

2.0k total citations
57 papers, 968 citations indexed

About

Ka-On Lam is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ka-On Lam has authored 57 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 21 papers in Surgery. Recurrent topics in Ka-On Lam's work include Head and Neck Cancer Studies (15 papers), Gastric Cancer Management and Outcomes (14 papers) and Lung Cancer Treatments and Mutations (11 papers). Ka-On Lam is often cited by papers focused on Head and Neck Cancer Studies (15 papers), Gastric Cancer Management and Outcomes (14 papers) and Lung Cancer Treatments and Mutations (11 papers). Ka-On Lam collaborates with scholars based in Hong Kong, China and United States. Ka-On Lam's co-authors include Victor Lee, Dora L.�W. Kwong, Cheuk‐Wai Choi, To‐Wai Leung, Wing‐Lok Chan, Anne W.M. Lee, Kwok-Keung Yuen, Chi‐Chung Tong, Varut Vardhanabhuti and Dora Lai‐Wan Kwong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ka-On Lam

56 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ka-On Lam Hong Kong 19 443 368 225 222 200 57 968
Sung‐Ja Ahn South Korea 21 512 1.2× 619 1.7× 273 1.2× 308 1.4× 175 0.9× 113 1.5k
Kosj Yamoah United States 19 433 1.0× 791 2.1× 168 0.7× 164 0.7× 228 1.1× 102 1.4k
J-P. Machiels Belgium 17 676 1.5× 432 1.2× 419 1.9× 114 0.5× 226 1.1× 53 1.2k
Katrien Vandecasteele Belgium 19 290 0.7× 477 1.3× 211 0.9× 255 1.1× 129 0.6× 57 1.1k
V. Georgoulias Greece 18 731 1.7× 386 1.0× 152 0.7× 413 1.9× 263 1.3× 51 1.4k
Pu‐Yun OuYang China 19 528 1.2× 489 1.3× 410 1.8× 205 0.9× 117 0.6× 48 1.1k
Pramila R. Anné United States 19 536 1.2× 494 1.3× 484 2.2× 269 1.2× 78 0.4× 48 1.1k
Josiane Otto France 20 1.1k 2.5× 906 2.5× 175 0.8× 204 0.9× 228 1.1× 59 1.6k
Kian Fong Foo Singapore 13 320 0.7× 238 0.6× 193 0.9× 47 0.2× 141 0.7× 24 712
Carles Escriu United Kingdom 9 786 1.8× 1.5k 4.1× 173 0.8× 424 1.9× 253 1.3× 29 1.9k

Countries citing papers authored by Ka-On Lam

Since Specialization
Citations

This map shows the geographic impact of Ka-On Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ka-On Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ka-On Lam more than expected).

Fields of papers citing papers by Ka-On Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ka-On Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ka-On Lam. The network helps show where Ka-On Lam may publish in the future.

Co-authorship network of co-authors of Ka-On Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Ka-On Lam. A scholar is included among the top collaborators of Ka-On Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ka-On Lam. Ka-On Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chan, Wing‐Lok, Carlos King Ho Wong, Yhi Wong, et al.. (2023). Adjuvant Chemotherapy in Older Patients with Gastric Cancer: A Population-Based Cohort Study. Cancers. 15(15). 3768–3768. 2 indexed citations
3.
Zhang, Feifei, Chen Jiang, Xinyue Wang, et al.. (2023). ARHGAP15 promotes metastatic colonization in gastric cancer by suppressing RAC1-ROS pathway. PLoS Genetics. 19(2). e1010640–e1010640. 5 indexed citations
5.
O’Sullivan, Brian, Shao Hui Huang, Ka-On Lam, et al.. (2022). An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma. Cancers. 14(8). 1923–1923. 3 indexed citations
6.
Chan, Wing‐Lok, Cheuk‐Wai Choi, Brian Hung‐Hin Lang, et al.. (2021). Health-Related Quality of Life in Asian Differentiated Thyroid Cancer Survivors. Cancer Control. 28. 2895447774–2895447774. 25 indexed citations
7.
Lam, Ka-On, Sum‐Yin Chan, Ivan Hung, et al.. (2021). Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report. BMC Infectious Diseases. 21(1). 1148–1148. 7 indexed citations
9.
Lee, Shing Fung, Cheuk‐Wai Choi, Ka Man Cheung, et al.. (2021). External Validation of a Nomogram to Predict Survival and Benefit of Concurrent Chemoradiation for Stage II Nasopharyngeal Carcinoma. Cancers. 13(17). 4286–4286. 5 indexed citations
10.
Huang, Jiao, Feifei Zhang, Zhaojie Lv, et al.. (2020). ORAI2 Promotes Gastric Cancer Tumorigenicity and Metastasis through PI3K/Akt Signaling and MAPK-Dependent Focal Adhesion Disassembly. Cancer Research. 81(4). 986–1000. 86 indexed citations
11.
Du, Richard, Victor Lee, Hui Yuan, et al.. (2019). Radiomics Model to Predict Early Progression of Nonmetastatic Nasopharyngeal Carcinoma after Intensity Modulation Radiation Therapy: A Multicenter Study. Radiology Artificial Intelligence. 1(4). e180075–e180075. 46 indexed citations
12.
Nicholls, John M., Victor Lee, Cheuk‐Wai Choi, et al.. (2019). Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes. British Journal of Cancer. 121(8). 690–698. 25 indexed citations
13.
Lam, Ka-On & Dora L.�W. Kwong. (2018). Target Therapy for Esophageal Adenocarcinoma. Methods in molecular biology. 1756. 51–65. 2 indexed citations
14.
Lam, Ka-On & Dora L.�W. Kwong. (2018). Chemotherapy for Esophageal Adenocarcinoma. Methods in molecular biology. 1756. 19–34. 1 indexed citations
15.
Zeng, Zhao‐Chong, Jinsil Seong, Sang Min Yoon, et al.. (2017). Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting. Liver Cancer. 6(4). 264–274. 49 indexed citations
16.
Lee, Victor, Dora L.�W. Kwong, To‐Wai Leung, et al.. (2017). Palliative systemic therapy for recurrent or metastatic nasopharyngeal carcinoma – How far have we achieved?. Critical Reviews in Oncology/Hematology. 114. 13–23. 39 indexed citations
17.
Lee, Victor, Anthony W.I. Lo, William Leung, et al.. (2016). Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma. PLoS ONE. 11(6). e0157969–e0157969. 54 indexed citations
18.
Lee, Victor, Weijia Fang, Ka-On Lam, et al.. (2015). Impact of CAPOX or FOLFOX4 on Spleen size, Platelet Count and Liver Function when Partnered Cetuximab as First-line Treatment for KRAS Wild-type Metastatic Colorectal Cancer. The HKU Scholars Hub (University of Hong Kong). 1(1). 60–74. 1 indexed citations
19.
Lam, Ka-On, Anne W.M. Lee, Cheuk‐Wai Choi, et al.. (2015). Global Pattern of Nasopharyngeal Cancer: Correlation of Outcome With Access to Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 94(5). 1106–1112. 23 indexed citations
20.
Lee, Victor, Vicky P.C. Tin, Tim‐Shing Choy, et al.. (2013). Association of Exon 19 and 21 EGFR Mutation Patterns with Treatment Outcome after First-Line Tyrosine Kinase Inhibitor in Metastatic Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 8(9). 1148–1155. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026